PHARMACYTE BIOTECH, INC. Notes Payable, Current
PHARMACYTE BIOTECH, INC. (PMCB) had Notes Payable, Current of $310.00 thousand as of 2012-07-31, per its 10-Q filed 2012-09-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes and Loans Payable, Current
us-gaap:NotesPayableCurrent · last filed 2012-09-19
- 2012-07-31: Notes Payable, Current $310.00K.
| Period end | Notes Payable, Current |
|---|---|
| 2012-07-31 | $310.00K 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |